Adarotene

Drug Profile

Adarotene

Alternative Names: ST 1926

Latest Information Update: 23 Aug 2010

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator sigma-tau SpA
  • Class Antineoplastics; Retinoids
  • Mechanism of Action Apoptosis stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Solid tumours

Most Recent Events

  • 05 Mar 2007 Phase-I clinical trials in Solid tumours in Italy (unspecified route)
  • 11 Dec 2006 Data presented at the 18th EORTC-NCI-ACCI Symposium on Molecular Targets and Cancer Therapeutics (EORTC-NCI-ACCI 2006) added to the Cancer pharmacodynamics section
  • 16 Apr 2004 Data presented at the 95th Annual Meeting of the American Association for Cancer Research (AACR-2004) have been added to the Cancer pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top